Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are u... Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.4598 | 5.29113924051 | 8.69 | 9.2476 | 8.37 | 822628 | 8.85363525 | CS |
| 4 | 0.4498 | 5.17011494253 | 8.7 | 9.2476 | 7.71 | 1001126 | 8.42640195 | CS |
| 12 | 0.3626 | 4.12645666424 | 8.7872 | 14.4405 | 7.71 | 1681087 | 10.30493083 | CS |
| 26 | 3.8398 | 72.3126177024 | 5.31 | 14.4405 | 5.03 | 1379436 | 9.02980509 | CS |
| 52 | 3.8798 | 73.6204933586 | 5.27 | 14.4405 | 3.25 | 1258753 | 7.08348094 | CS |
| 156 | -1.8202 | -16.5925250684 | 10.97 | 15.24 | 3.25 | 1203587 | 8.36563569 | CS |
| 260 | 6.2198 | 212.279863481 | 2.93 | 31.5 | 2.2 | 1346436 | 10.72384081 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
